Loading...
Loading...
is scheduled to report its November sales on Wednesday before market open.
Ricky Goldwasser of Morgan Stanley is expecting Walgreens to report a total sales comp of 4.2 percent year over year, or 5.6 percent adjusted for calendar day shift impact. The analyst's estimates represent a decrease from the 5.9 percent adjusted comp the company reported in October.
Goldwasser's estimates reflects a pharmacy sales comp estimate of 5.7 percent (7.9 percent adjusted) and a pharmacy script comp of 1.7 percent year over year (3.9 percent adjusted), down from an adjusted comp of 4.1 percent in October.
The analyst also expects Walgreens to report a front-end comp of 1.3 percent year over year, down from the 2.0 percent the company reported in October.
Shares are Overweight rated with a $77 price target.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in